Precision Biosciences Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 11.94, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Precision Biosciences Inc in Mar 31 2026 quarter, has decreased to 31 days, compared to 46 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 76 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 745, from overall ranking in the fourth quarter 2025 at 2373.

What is Receivable Turnover Ratio?
What is Precision Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DTIL Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-35.7 %	-	-3.57 %	-8.19 %	-13.69 %
Y / Y Revenue Change	37272.41 %	5261.13 %	-97.74 %	-99.96 %	-99.84 %
Receivable Turnover Ratio (TTM)	11.94	7.91	0.13	0.23	8.95
DTIL's Total Ranking	# 745	# 2373	# 3598	# 3448	# 3372
Accounts Receivable average collection period days	31	46	2896	1618	41
Seq. Receivable Change	-	-	-6.21 %	-7.89 %	28.77 %
Seq. Revenue Change	-68.31 %	263007.69 %	-27.78 %	-37.93 %	-95.45 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 11
Healthcare Sector	# 77
Overall Market	# 745

Receivable Turnover Ratio Statistics
High	Average	Low
25.95	5.78	0.13
(Mar 31 2022)		(Sep 30 2025)

DTIL Company Profile • Back to DTIL Efficiency Comparisons • Compare DTIL Receivables Turnover Ratio to its Competitors

Financial Statements
Precision Biosciences Inc's Accounts Receivable	$ 4 Millions	Visit DTIL's Balance sheet
Precision Biosciences Inc's Sales TTM	$ 45 Millions	Visit DTIL's Income Statement
Sources of DTIL's Revenues		Visit DTIL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DTIL's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DTIL's Growth Rates	DTIL's Roa	DTIL's Inventory Turnover Ratio	DTIL's Dividend Comparisons
DTIL's Profitability Ratios	DTIL's Roi	DTIL's Asset Turnover Ratio	DTIL's Dividend Growth
DTIL's Valuation Ratios	DTIL's Roe	DTIL's Financial Strength Ratios	DTIL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
U S Physical Therapy Inc	30.94	$ 795.488 Millions	$ 25.708 Millions
Innovage Holding Corp	30.93	$ 949.172 Millions	$ 30.688 Millions
Atara Biotherapeutics Inc	29.74	$ 23.540 Millions	$ 0.792 Millions
Invo Fertility Inc	29.40	$ 7.219 Millions	$ 0.246 Millions
Lineage Cell Therapeutics Inc	28.42	$ 14.779 Millions	$ 0.520 Millions
Meiragtx Holdings Plc	28.01	$ 79.758 Millions	$ 2.848 Millions
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions
Wave Life Sciences Ltd	27.36	$ 88.173 Millions	$ 3.223 Millions
Safe Pro Group Inc	27.29	$ 1.642 Millions	$ 0.060 Millions
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Jaguar Health Inc	24.65	$ 29.569 Millions	$ 1.200 Millions
Kiniksa Pharmaceuticals International Plc	24.63	$ 754.045 Millions	$ 30.618 Millions
Polomar Health Services, Inc.	24.47	$ 1.649 Millions	$ 0.067 Millions
Agenus Inc	24.33	$ 123.866 Millions	$ 5.091 Millions
Igc Pharma Inc	23.44	$ 1.166 Millions	$ 0.050 Millions
Cytomx Therapeutics Inc	23.09	$ 35.542 Millions	$ 1.539 Millions
Siga Technologies Inc	22.41	$ 93.777 Millions	$ 4.186 Millions
Lipocine Inc	22.09	$ 2.002 Millions	$ 0.091 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions

Date modified: 2026-08-29T17:40:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.